- Home
- CTNM vs LZM Comparison
CTNM vs LZM Comparison
Compare CTNM & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- LZM
- Stock Information
- Founded
- CTNM 2009
- LZM 2021
- Country
- CTNM United States
- LZM Isle of Man
- Employees
- CTNM N/A
- LZM N/A
- Industry
- CTNM
- LZM Metal Mining
- Sector
- CTNM
- LZM Basic Materials
- Exchange
- CTNM Nasdaq
- LZM Nasdaq
- Market Cap
- CTNM 328.1M
- LZM 333.0M
- IPO Year
- CTNM 2024
- LZM N/A
- Fundamental
- Price
- CTNM $10.93
- LZM $3.80
- Analyst Decision
- CTNM Strong Buy
- LZM Strong Buy
- Analyst Count
- CTNM 5
- LZM 2
- Target Price
- CTNM $20.40
- LZM $10.50
- AVG Volume (30 Days)
- CTNM 166.5K
- LZM 200.5K
- Earning Date
- CTNM 10-30-2025
- LZM 08-11-2025
- Dividend Yield
- CTNM N/A
- LZM N/A
- EPS Growth
- CTNM N/A
- LZM N/A
- EPS
- CTNM N/A
- LZM N/A
- Revenue
- CTNM N/A
- LZM $416,323.00
- Revenue This Year
- CTNM N/A
- LZM $611.56
- Revenue Next Year
- CTNM N/A
- LZM $344.44
- P/E Ratio
- CTNM N/A
- LZM N/A
- Revenue Growth
- CTNM N/A
- LZM N/A
- 52 Week Low
- CTNM $3.35
- LZM $2.90
- 52 Week High
- CTNM $16.25
- LZM $7.29
- Technical
- Relative Strength Index (RSI)
- CTNM 47.95
- LZM 34.22
- Support Level
- CTNM $10.46
- LZM $3.60
- Resistance Level
- CTNM $13.09
- LZM $3.96
- Average True Range (ATR)
- CTNM 0.98
- LZM 0.31
- MACD
- CTNM 0.08
- LZM -0.02
- Stochastic Oscillator
- CTNM 29.68
- LZM 19.81
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About LZM Lifezone Metals Limited
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.